Objective: To determine the frequency of antistreptolysin O (ASLO) positivity in cases of proven chronic tonsillitis.
INTRODUCTION
Group A streptococcal (GAS) tonsillitis presents with abrupt onset of sore throat, tonsillar exudate, tender cervical adenopathy, and fever, followed by spontaneous resolution within 2 to 5 days. Streptococcal tonsillitis could result in various complications, such as suppurative (peritonsillar abscess, cervical lymphadenitis and mastoiditis) and non suppu rative complications (acute rheumatic fever, glome rulonephritis, PANDAS syndrome). Although symptoms of GAS pharyngitis resolve with out antibiotic therapy, persistence of the organisms in the upper respiratory tract elicits an immune response that can set the stage for subsequent risk of acute rheumatic fever (ARF) if the strain is rheumatogenic and the host is genetically predisposed. In some population, groups G and C streptococci may also play a role in ARF pathogenesis. Evaluation of GAS tonsillitis therapies has been based upon GAS eradication from the upper respiratory tract; it is assumed that such eradication is an adequate surrogate marker for efficacy in primary prevention of rheumatic fever.
2 Antibiotic therapy can be helpful for prevention of rheumatic fever if initiated up to 9 days following onset of symptoms. Goals of antimicrobial therapy for eradication of GAS from the pharynx in the setting of acute streptococcal pharyngitis include the following:
• Reducing duration and severity of clinical signs and symptoms (suppurative complications).
• Reducing incidence of nonsuppurative complications (acute rheumatic fever).
• Reducing transmission to close contacts by reducing infectivity. The present study aims at determining the frequency of antistreptolysin O (ASLO) positivity in cases of proven chronic tonsillitis.
MATERIALS AND METHODS
This is a time bound crosssectional study done on 150 patients with clinically diagnosed chronic tonsillitis and willing for tonsillectomy at a tertiary health center over a period of 10 months from January 2013 to October 2013.
The patients ranged from 5 to 34 years (Table 1) . A total of 70 patients were males and 80 females. On admission, a pro forma was filled for each patient documenting age, sex, address, and clinical information, including chief com plaints and duration of symptoms. Following this, a detailed otorhinolaryngological and general physical examination was done. Investigations including complete blood counts, bleeding time, clotting time, blood urea, serum creatinine HIV, HBsAg, ECG, chest Xray, RF, ASLO titers (Table 2) , and urine routine examination were done for all patients prior to surgery. Following the physicians and anesthetic fitness, the patient was posted for tonsillectomy with or without adenoidectomy under general anesthesia and the tonsillar specimens were sent for histopathological examination.
Statistical analysis of results was carried out using statistical package for social science (SPSS) version 13. Level of significance is considered <0.05 for chi-square test and >0.4 for kappa.
RESULTS
Majority of the patients were in the age group of 5 to 14 years (46%). Overall, there was a female predominance.
Five out of the 150 patients had ASLO titer positivity (>200 IU/ml).
During a 6month postoperative followup, three of the five cases showed negative ASLO titers.
DISCUSSION
ASLO testing is an essential tool in chronic tonsillitis as it can be used in the early detection of group A betahemolytic streptococcal tonsillitis as well as in the effective medical and surgical management of the same. 3 Followup test of cure is appropriate for asymptomatic index patients and their asymptomatic household contacts in the following circumstances:
• Individuals with history of rheumatic fever • Individuals who develop acute pharyngitis during an outbreak of acute rheumatic fever or acute poststrepto coccal glomerulonephritis • Spread of GAS among several family members.
In case of a recurrent streptococcal tonsillitis or sero logical positivity, they should receive a standard course of antimicrobial therapy (penicillin/1st generation cephalo sporins). 4 Repeated treatment should be administered with an agent with greater betalactamase stability than the pre vious agent. If penicillin was used for initial therapy, repeat treatment with amoxicillinclavulanate or a 1st generation cephalosporin may be used; if initial treatment was with a 1st generation cephalosporin, a 2nd or 3rd generation cephalosporin may be used. 5 The statistical conclusions made in our studies proved that serological testing in clinically proven cases of chronic tonsillitis could be detrimental in assessing the likelihood of GABS tonsillitis and their subsequent complications.
CONCLUSION
Early detection and treatment of streptococcal tonsillar involvement could be a preventive measure against the future predilection of other predisposed organs to more severe and debilitating streptococcal infections.
Further studies are required to ascertain the following: 1. ASLO titer estimation as a part of routine workup in chronic tonsillitis patients. 2. Would ASLO positivity become a relative indication for tonsillectomy? 3. Duration for posttonsillectomy ASLO negativity. 4. Incidence of ASLO positive chronic tonsillitis and associa tion with rheumatic fever, scarlet fever, post streptococcal glomerulonephritis and PANDAS syndrome). 
